Published in J Am Heart Assoc on June 14, 2013
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World J Hepatol (2015) 0.83
Different degrees of NADPH oxidase 2 regulation and in vivo platelet activation: lesson from chronic granulomatous disease. J Am Heart Assoc (2014) 0.77
Low dose of acetylsalicylic acid and oxidative stress-mediated endothelial dysfunction in diabetes: a short-term evaluation. Acta Diabetol (2014) 0.75
Moderate physical training attenuates perinatal low-protein-induced spleen lymphocyte apoptosis in endotoxemic adult offspring rats. Eur J Nutr (2015) 0.75
Diagnosis and classification of diabetes mellitus. Diabetes Care (2011) 9.37
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A (1990) 5.31
Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57
Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation (2003) 2.77
Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol (2007) 2.38
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol (1997) 1.38
Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol (2009) 1.22
Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation (2009) 1.19
Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction. Arterioscler Thromb Vasc Biol (2010) 1.17
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation (2003) 1.16
Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients. Atherosclerosis (2010) 0.92
Isoprostane measurement in plasma and urine by liquid chromatography-mass spectrometry with one-step sample preparation. Clin Chem (2007) 0.90
Platelet isoprostane overproduction in diabetic patients treated with aspirin. Diabetes (2012) 0.85
Oxidative stress in patients affected by primary aldosteronism. J Hypertens (2014) 3.34
Portal vein thrombosis in liver cirrhosis. Intern Emerg Med (2008) 2.33
Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood (2013) 2.27
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study. Eur Heart J (2004) 2.18
Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet (2009) 2.12
NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation. Liver Int (2011) 2.09
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. J Am Coll Cardiol (2013) 2.05
Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy. Hepatology (2007) 1.85
Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J (2007) 1.67
Bleeding and thrombosis in cirrhotic patients: what really matters? Dig Liver Dis (2011) 1.54
99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging (2005) 1.51
Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque. Arterioscler Thromb Vasc Biol (2003) 1.51
The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes. Eur J Intern Med (2010) 1.50
Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension. Chest (2012) 1.48
Enhanced platelet release of superoxide anion in systemic hypertension: role of AT1 receptors. J Hypertens (2004) 1.48
Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis. Thromb Haemost (2010) 1.41
New oral anticoagulants for the treatment of acute venous thromboembolism: are they safer than vitamin K antagonists? A meta-analysis of the interventional trials. Intern Emerg Med (2014) 1.40
The association between hyperhomocysteinemia and ischemic stroke in patients with non-valvular atrial fibrillation. Haematologica (2005) 1.39
Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis (2002) 1.24
Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol (2009) 1.22
Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship. Haematologica (2009) 1.20
Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation (2009) 1.19
Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction. Arterioscler Thromb Vasc Biol (2010) 1.17
Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. J Am Coll Cardiol (2004) 1.15
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility. Carcinogenesis (2012) 1.14
Caloric restriction may reverse age-related autonomic decline in humans. Aging Cell (2012) 1.10
Interventional trials with anticoagulants in acutely ill medical patients: a methodological pitfall? Intern Emerg Med (2013) 1.09
Comment on "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property". Dig Liver Dis (2012) 1.09
Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. Free Radic Biol Med (2006) 1.08
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype. Arch Neurol (2007) 1.07
Congenital dyserythropoietic anemias. Curr Opin Hematol (2011) 1.06
Long-term calorie restriction, but not endurance exercise, lowers core body temperature in humans. Aging (Albany NY) (2011) 1.04
Oxidative stress and antioxidant therapy in cystic fibrosis. Biochim Biophys Acta (2011) 1.03
Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2. Circulation (2012) 1.03
Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis (2006) 1.02
Statins as antithrombotic drugs. Circulation (2013) 1.00
Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance. Biochimie (2012) 1.00
Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation (2005) 1.00
Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d in erythroid cells. Haematologica (2010) 0.99
Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment. BMC Pulm Med (2012) 0.99
Obstructive sleep apnoea syndrome and the metabolic syndrome in an internal medicine setting. Eur J Intern Med (2010) 0.99
Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach. Haematologica (2012) 0.99
Reduced atherosclerotic burden in subjects with genetically determined low oxidative stress. Arterioscler Thromb Vasc Biol (2013) 0.98
Simultaneous, stability indicating, HPLC-DAD determination of guaifenesin and methyl and propyl-parabens in cough syrup. J Pharm Biomed Anal (2006) 0.98
Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation. Cardiovasc Diabetol (2009) 0.98
Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. Blood (2005) 0.98
Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness. Mol Med (2009) 0.97
Successful hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia type II. Pediatr Transplant (2014) 0.97
In vivo interconversion of 7beta-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress. Free Radic Biol Med (2007) 0.97
Missense mutations in the ABCB6 transporter cause dominant familial pseudohyperkalemia. Am J Hematol (2012) 0.96
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr (2008) 0.95
A predicted functional single-nucleotide polymorphism of bone morphogenetic protein-4 gene affects mRNA expression and shows a significant association with cutaneous melanoma in Southern Italian population. J Cancer Res Clin Oncol (2009) 0.93
Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: Effect of ascorbic acid. Free Radic Biol Med (2007) 0.92
Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients. Atherosclerosis (2010) 0.92
Role of NADPH oxidase in atherosclerosis. Future Cardiol (2009) 0.92
Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2- production. Thromb Haemost (2003) 0.91
Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type. J Alzheimers Dis (2012) 0.91
Effects of resveratrol and other wine polyphenols on vascular function: an update. J Nutr Biochem (2010) 0.91
Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. Stroke (2011) 0.91
Platelet oxidative stress and thrombosis. Thromb Res (2011) 0.91
Chocolate, lifestyle, and health. Crit Rev Food Sci Nutr (2009) 0.90
Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets. Haematologica (2002) 0.90
Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation. Biochem Pharmacol (2012) 0.90
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Am J Hematol (2012) 0.89
Hyperfibrinolysis in liver disease. Clin Liver Dis (2009) 0.89
Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. J Lab Clin Med (2005) 0.89
Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia: the potential role of nicotinamide-adenine dinucleotide phosphate oxidase. Pediatrics (2008) 0.88
CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol (2005) 0.88